Advanced Lung Cancer
53
19
19
14
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.7%
3 terminated out of 53 trials
82.4%
-4.2% vs benchmark
0%
0 trials in Phase 3/4
7%
1 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 14 completed trials
Clinical Trials (53)
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002
Nurse-Led Caregiver Support for Older Adults With Advanced Lung Cancer
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
A Pilot Study of the VosCryoTM Breathalyser in Lung Cancer
Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer
Family-Supported Palliative Care in Advanced Lung Cancer
Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures
A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors
Engage Psychosocial Intervention for Cancer Symptoms
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension